Martin Shkreli
News/ News/ Sales and Marketing
Shkreli’s former company pays $40m in price-gouging settlement
Phil Taylor
daraprim, drug prices, infectious disease, Martin Shkreli, price gouging, Vyera Pharmaceuticals
0 Comment
News/ News/ Sales and Marketing
Martin Shkreli’s $7.4m forfeit is paid, thanks to that Wu-Tang Clan album
Phil Taylor
Legal, litigation, Martin Shkreli, pricing
0 Comment
‘Delusional’ Shkreli refused prison release to fight coronavirus
Richard Staines
coronavirus, COVID-19, litigation, market access, Martin Shkreli, pricing
0 Comment
Pharma bad boy Shkreli asks for prison release to fight COVID-19
Richard Staines
coronavirus, COVID-19, Martin Shkreli, pricing, R&D
0 Comment
Outrage at Marathon’s ‘new drug’ price, calls for PhRMA to act
Richard Staines
Donald Trump, drug prices, Duchenne muscular dystrophy, fda, FDA approvals 2017, Martin Shkreli, orphan, regulation
0 Comment
Marathon under fire after US price hike.